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Available online 25 September 2011The conclusions drawn in the large retrospective study of
Rantner and coworkers (early carotid endarterectomy
(CEA) is safe and will prevent stroke in the majority of
patients) are clear, but might need some refinements.1 At
present, we cannot tar every patient with a symptomatic
carotid stenosis with the same brush. Rerkasem et al.
performed a systemic review of the operative risks of CEA
for recently symptomatic patients in relation to timing of
surgery.2 The pooled absolute risks of stroke and death
after urgent CEA were up to 20% in patients with stroke-in-
progress, and 11.4% in patients with crescendo transient
ischemic attacks (TIA). Only in the group of neurologically
stable patients (TIA or minor stroke) no differences were
found between early (<1 week) and delayed surgery.
Similar findings have been published in a meta-analysis of
Patterson and coworkers (odds ratio of 5.6 for combined
stroke/death in patients with crescendo TIAs in comparison
with CEA for stable patients, and an odds ratio of 5.5 for
patients with unstable stroke).3 Therefore, the decision
whether or not to perform urgent CEA must be more indi-
vidualized. Several important aspects have to be taken into
account and tackled. Until now, there is a lack of consensus
concerning the definitions used for crescendo TIAs and
stroke-in-progress or unstable stroke. Uniform definitionsDOI of original article: 10.1016/j.ejvs.2011.08.004.
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Within these particular subgroups patients at highest risk for
peri-CEA complications should be identified. Criteria like
the American Society of Anesthesiologists class and Rankin
scores can be used, but clinical scoring systems might fall
short. As stated by Rantner et al. neuroimaging should be
performed in every symptomatic carotid patient to identify
morphological defects. The occurrence of defects will
increase the risk of complications during urgent repair.
Another modality is the use of magnetic resonance imaging
(MRI) to demonstrate diffusion-perfusion mismatch for
identification of reversible ischemic brain lesions.
During the coming years non-invasive evaluation of
carotid plaque vulnerability is expected to increase enor-
mously, with the implementation of dedicated positron
emission tomography, 7-T MRI, (plaque) biomarkers, etc. It
seems reasonable to reserve urgent CEA for the most
vulnerable carotid plaques.
Finally, we need to improve best medical treatment for
the subgroup of patients deemed unfit for surgery and for
patients in whom urgent CEA has to be postponed because of
large morphological defects at initial scans. Besides opti-
mization of the well-known vascular risk factors, carotid
plaque stabilizing medication may be prescribed to reduce
plaque inflammation and risk for new adverse events.4
It can be concluded that urgent CEA for symptomatic
carotid stenosis is safe and must be performed in neuro-
logically stable patients. However, more research has to be
performed for tailor made treatment of high risk patients
with unstable symptoms and morphologic defects at initiald by Elsevier Ltd. All rights reserved.
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it appears reasonably to try to identify patients who should
not be operated at all but have to be treated with plaque
stabilizing medication.
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